Want to join the conversation?
On Sept. 14, 2015, $MYL announced the initiation of the Phase 3 program in the US supporting the registrational development program of TD-4208. In addition to this, $MYL made a $30MM investment in Theravance Biopharma's common stock during 1Q15. $MYL incurred $15MM in upfront development costs during the nine months ended Sept. 30, 2015.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!